US Patent 7714138 Monocyclic heterocycles as kinase inhibitors
Patent 7714138 was granted and assigned to Bristol-Myers Squibb on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+80 characters)
Article
Patent abstract
The present invention is directed to compounds having the formula
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Gretchen M. Schroeder0
Kyoung S. Kim0
Lyndon A. M. Cornelius0
Robert J. Schmidt0
Robert M. Borzilleri0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07714138 Monocyclic heterocycles as kinase inhibitors US Patent 7714138 Monocyclic heterocycles as kinase inhibitors
Infobox
Patent Number
077141380
Patent Number
77141380
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077141380
Date of Patent
May 11, 2010
0Patent Application Number
122534910
Date Filed
October 17, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07714138 Monocyclic heterocycles as kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07714138
Date of patent
May 11, 2010
Patent application number
12253491
Date Filed
October 17, 2008
Patent primary examiner
Find more entities like US Patent 7714138 Monocyclic heterocycles as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
